No abstract available
MeSH terms
-
Cardiovascular Agents / economics
-
Cardiovascular Agents / therapeutic use
-
Confidentiality*
-
Cost-Benefit Analysis
-
Drug Costs*
-
Drug Industry*
-
Evidence-Based Medicine / standards*
-
Humans
-
RNA, Small Interfering / economics
-
RNA, Small Interfering / therapeutic use
-
State Medicine / standards*
-
United Kingdom
Substances
-
ALN-PCS
-
Cardiovascular Agents
-
RNA, Small Interfering